| |
|
|
|
Axovant Sciences Ltd  
|
|
3.61 -0.15 (-0.04%) |
10-19 16:00 |
|
Open: |
3.9 |
Pre close: |
3.76 |
Target:
|
5.62 
|
|
High: |
3.95 |
Low: |
3.56 |
Resistance:
|
4.81
5.74
|
|
Volume: |
2,489,856 |
Market Cap: |
171M |
Support:
|
3.31
2.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.61
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
4.22 |
Signal(12,26,9): |
0.09 |
|
MA(100): |
3.37 |
Stochastic Oscillator |
%K(14,3):
|
7.90 |
|
MA(250): |
3.81 |
%D(3): |
5.22 |
|
Average Volume(K) |
3-Month: |
141979
|
52-Week |
High:
|
6.93 |
|
10-Days: |
391123 |
Low: |
1.41 |
|
RSI |
RSI(14):
|
45.82 |
Change(%): |
-34.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.776 |
Return on Equity (ttm) |
-120.9 |
Shares Out. (M) |
47.25 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-37.3 |
Shares Float (M) |
16.74 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
47.58 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.87 |
|
Forward EPS |
-8.020 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
266 |
|
Book Value (p.s.) |
1.430 |
EBITDA (p.s.) |
-1.056 |
P/E |
-2.03 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.52 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-63.24 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-40.86 |
P/CF |
-2.70 |
|
|
|
|
|
|
